Cardiol Therapeutics
Organisation
Trials
Phase 3, Recruiting, 110 people, 27 Nov 2024
Phase 2, Completed, 27 people, 10 Aug 2022
Phase 2, Completed, 109 people, 6 Jan 2022
Phase 2/3, Terminated, 90 people, 4 Nov 2020
Organisation
Phase 3, Recruiting, 110 people, 27 Nov 2024
Phase 2, Completed, 27 people, 10 Aug 2022
Phase 2, Completed, 109 people, 6 Jan 2022
Phase 2/3, Terminated, 90 people, 4 Nov 2020